Tag: DESTINY1
Poxel Presents Phase II (DESTINY-1) Results of PXL065 for the Treatment of NASH at AASLD The Liver Meeting® 2022 – 11/07/2022 8:15 PM
– “Late-breaking abstract” selected by the AASLD as one of the best of the 2022 edition (“Best of the Liver Meeting”) – The phase II study of PXL065 for the…